Global Thalassemia Treatment Market Analysis, Size, Share, Growth, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2021 to 2028
Published Date: Dec 2021
No. of Pages: 150
Status: Published
Report Code: ARI101004
Global Thalassemia Treatment Market:
Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025. Rise in number of altered Thalassemia genes, increase in awareness about the disease and high adoption of chelation therapy & blood transfusion for treatment by doctors as well as patients are likely to enhance the growth of Global Thalassemia Treatment Market.
Scope of Thalassemia Treatment Market Reports:
Thalassemia is an inherited blood disorder in which the body makes an abnormal form of hemoglobin. People having Thalassemia disease are unable to make sufficient hemoglobin which causes severe anemic conditions. Hemoglobin is found in red blood cells and transports oxygen to all parts of the body. When there is insufficient hemoglobin in the red blood cells, oxygen cannot get to all parts of the body. Organs demand oxygen and are unable to function properly. There are two primary types of Thalassemia disease such as Alpha Thalassemia disease and Beta Thalassemia disease. Alpha Thalassemia results in a formation of additional beta globins, which leads to the formation of beta-globin tetramers (β4) called Hemoglobin H.Beta Thalassemia causes additional formation of alpha globins, which develops alpha globin tetramers (α4) that store in the erythroblast (immature red blood cell).Thalassemia is caused by mutations in the DNA of cells that make hemoglobin. Factors that increase risk of Thalassemia include Family history of thalassemia and certain ancestry. Possible complications of Thalassemia include Iron overload, Infections, Bone deformities, splenomegaly, slowed growth rate of child and Heart problems. Thalassemia signs and symptoms include Fatigue, Weakness, Pale or yellowish skin, Facial bone deformities, slow growth, abdominal swelling, Dark urine, chest pain, cold hands and feet, poor feeding, greater susceptibility to infections. Diagnosis of Thalassemia includes a complete blood count (CBC), a reticulocyte count, Iron count, Genetic testing and prenatal testing. Treatment of Thalassemia depends on the type and severity of Thalassemia such as Blood transfusions, Bone marrow or stem cell transplant, Surgery and Gene therapy. Global Thalassemia Treatment Market has been segmented on the basis of Type of Treatment, Diagnosis, End users and Geography. On the basis of Type of Treatment Global Thalassemia Treatment Market is classified into Blood Transfusion, Chelating Therapy, Bone Marrow Transplant, Stem Cell Transplant, Surgery, Gene Therapy and Others. On the basis of Diagnosis Global Thalassemia Treatment Market is classified into Perinatal Testing, Prenatal Testing, Pre-Implantation and Other. On the basis of the End user the Global Thalassemia Treatment Market is classified into Hospitals, Biotechnological Laboratories, Diagnostic Laboratories, Educational Research Institutes, Pharmaceutical Industries and others. The regions covered in Global Thalassemia Treatment Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Market Dynamics:
Increase in awareness about the disease and technological expansions are likely to raise the adoption of gene therapies. Also Rising Prevalence of Thalassemia, Increase in Pharmaceutical R&D Spending, Increasing Spending on Stem Cell Research, Rising Healthcare Expenditure and Rising Asian Population will boost the Global Thalassemia Treatment Market. Treatment of Thalassemia is mostly restricted to regular blood transfusions and iron chelation therapy. Moreover, High operation cost of sophisticated clinical and preclinical imaging systems, High cost of maintenance and less life span of accessories also restraining the Global Thalassemia Treatment Market. Yearly spending for treatment of Thalassemia ranged from $ 108 to 432, depending on type of treatment with average cost per blood transfusion was $ 5.2±2.2. Average 18.5%±14.3 of the total annual income was spent on the treatment for Thalassemia. Drugs prescribed for Thalassemia mostly cures symptoms and side effects such as anemia, iron overload, slow growth of children and vitamin deficiency. Occurrence of Thalassemia is reported to increase steadily over the years across different regions. This can be due to population migration, intermarriages, genetic as well as environmental factors prompting the condition and its implications. Systematic Drugs under Pipeline, Rising Scope for Gene Therapy and increasing awareness towards Thalassemia are some opportunities in the forecast period for the Global Thalassemia Treatment Market.
Regional Analysis:
North America have largest share of Global Thalassemia Treatment Market. It is mainly driven by quickly increasing immigrant population from tropical regions, rising number of population with Thalassemia carrier gene and rise in birth rates due to variation of genes among the population in the U.S. There are some prenatal tests available on the market to determine the possibility of alpha thalassemia including both invasive and non-invasive technique. The alpha thalassemia testing market has emergent trend in the countries with traditional groups like Mediterranean countries, African countries and few countries in Asia Pacific. Furthermore, in Asia Pacific region the growth in similar community marriage practices and high fertility rate with alpha thalassemia patients have been detected. This is expected to raise acceptance of blood transfusion and chelation therapy treatments during the forecast period. A latest improvement in the testing of alpha Thalassemia may determine the risk of the disease by in vitro examination of the embryo. While there are various such tests available in the Global Thalassemia Treatment Market but lack of awareness leads to the neglect and delayed diagnosis of the diseased state. Most frequently prone area for alpha thalassemia is Mediterranean countries, African countries, and Southeast Asian countries. Thalassemia trait practically affects 6% to 35% of the population in these ethnic groups. Middle East & Africa is likely to be the fastest rising Global Thalassemia Treatment Market during the forecast period.
Key Players:
Bluebird bio Inc.
Acceleron Pharma Inc.
Novartis AG
Celgene Corporation
Shire plc
Bellicum Pharmaceuticals
GlaxoSmithKline Plc
Celgene
Lonza group
Alnylam Pharmaceuticals Inc.
Calimmune Inc.
CRISPR Therapeutics
Editas Medicine Inc.
Thalassemia Treatment Market Segmentation:
By Type
Blood Transfusion
Chelating Therapy
Bone Marrow Transplant
Stem Cell Transplant
Surgery
Gene Therapy
Other
By Diagnosis
Perinatal Testing
Prenatal Testing
Pre-Implantation
Other
By End User
Hospitals
Biotechnological Laboratories
Diagnostic Laboratories
Educational Research Institutes
Pharmaceutical Industries
Other
By Region
North America - US, Mexico, Chile, Canada
Europe - UK, France, Germany, Italy
Asia Pacific - China, South Korea, Japan, India, Southeast Asia
Latin America – Brazil
Middle East and Africa - GCC, Africa, Rest of Middle East and Africa
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Component
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. Perinatal Testing Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Thalassemia Treatment Market
Chapter 5. Global Thalassemia Treatment Market Overview, By Type, 2015 - 2028(USD Million)
5.1. Global Thalassemia Treatment Market Share, By Type, 2015 - 2028 (USD Million)
5.1.1. Blood Transfusion
5.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.2. Chelating Therapy
5.1.2.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.3. Bone Marrow Transplant
5.1.3.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.4. Stem Cell Transplant
5.1.4.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.5. Surgery
5.1.5.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.5.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.6. Gene Therapy
5.1.6.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.6.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.7. Other
5.1.7.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.7.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 6. Global Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028(USD Million)
6.1. Global Thalassemia Treatment Market Share, By Diagnosis, 2015 - 2028 (USD Million)
6.1.1. Perinatal Testing
6.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.2. Prenatal Testing
6.1.2.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.3. Pre-Implantation
6.1.3.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.4. Other
6.1.4.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 7. Global Thalassemia Treatment Market Overview, By End User, 2015 - 2028(USD Million)
7.1. Global Thalassemia Treatment Market Share, By End User, 2015 - 2028 (USD Million)
7.1.1. Hospitals
7.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.2. Biotechnological Laboratories
7.1.2.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.3. Diagnostic Laboratories
7.1.3.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.4. Educational Research Institutes
7.1.4.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.4.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.5. Pharmaceutical Industries
7.1.5.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.5.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.6. Other
7.1.6.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.6.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 8. Global Thalassemia Treatment Market Overview, By Geography, 2015 - 2028(USD Million)
8.1. Global Thalassemia Treatment Market Share, By Geography, 2015 - 2028(USD Million)
8.1.1. Market Size and projections, by Countries, 2015 - 2028 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2028 (%)
Chapter 9. North America Thalassemia Treatment Market Overview, By Countries, 2015 - 2028(USD Million)
9.1. North America Thalassemia Treatment Market Overview, 2015 - 2028 (USD Million)
9.1.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.2. North America Thalassemia Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
9.1.3. North America Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
9.1.4. North America Thalassemia Treatment Market Overview, By End User, 2015 - 2028 (USD Million)
9.1.5. North America Thalassemia Treatment Market Overview, By Countries, 2015 - 2028 (USD Million)
9.1.5.1. U.S. Thalassemia Treatment Market Overview, 2015 - 2028 (USD Million)
9.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.5.1.2. U.S. Thalassemia Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
9.1.5.1.3. U.S. Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
9.1.5.1.4. Other Segment
9.1.5.2. Canada Thalassemia Treatment Market Overview, 2015 - 2028 (USD Million)
9.1.5.2.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.5.2.2. Canada Thalassemia Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
9.1.5.2.3. Canada Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
9.1.5.2.4. Other Segment
9.1.5.3. Mexico Thalassemia Treatment Market Overview, 2015 - 2028 (USD Million)
9.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.5.3.2. Mexico Thalassemia Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
9.1.5.3.3. Mexico Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
9.1.5.3.4. Other Segment
Chapter 10. Europe Thalassemia Treatment Market Overview, By Countries, 2015 - 2028(USD Million)
10.1. Europe Thalassemia Treatment Market Overview, 2015 - 2028 (USD Million)
10.1.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.2. Europe Thalassemia Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
10.1.3. Europe Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
10.1.4. Europe Thalassemia Treatment Market Overview, By End User, 2015 - 2028 (USD Million)
10.1.5. Europe Skin Care Sizes Market Overview, By Countries, 2015 - 2028 (USD Million)
10.1.5.1. Germany
10.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.1.2. Germany Thalassemia Treatment Market Overview, By Type, 2015 - 2028(USD Million)
10.1.5.1.3. Germany Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028(USD Million)
10.1.5.1.4. Other Segment
10.1.5.2. France
10.1.5.2.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.2.2. France Thalassemia Treatment Market Overview, By Type, 2015 - 2028(USD Million)
10.1.5.2.3. France Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028(USD Million)
10.1.5.2.4. Other Segment
10.1.5.3. UK
10.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.3.2. UK Thalassemia Treatment Market Overview, By Type, 2015 - 2028(USD Million)
10.1.5.3.3. UK Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028(USD Million)
10.1.5.3.4. Other Segment
10.1.5.4. Italy
10.1.5.4.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.4.2. Italy Thalassemia Treatment Market Overview, By Type, 2015 - 2028(USD Million)
10.1.5.4.3. Italy Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028(USD Million)
10.1.5.4.4. Other Segment
10.1.5.5. Spain
10.1.5.5.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.5.2. Spain Thalassemia Treatment Market Overview, By Type, 2015 - 2028(USD Million)
10.1.5.5.3. Spain Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028(USD Million)
10.1.5.5.4. Other Segment
10.1.5.6. Rest of Europe
10.1.5.6.1. Market Size and projections, 2015 – 2028
10.1.5.6.2. Rest of Europe Thalassemia Treatment Market Overview, By Type, 2015 - 2028(USD Million)
10.1.5.6.3. Rest of Europe Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028(USD Million)
10.1.5.6.4. Other Segment
Chapter 11. Asia Pacific Thalassemia Treatment Market Overview, By Countries, 2015 - 2028 (USD Million)
11.1. Asia Pacific Thalassemia Treatment Market Overview, 2015 - 2028 (USD Million)
11.1.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.2. Asia Pacific Thalassemia Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
11.1.3. Asia Pacific Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
11.1.4. Asia Pacific Thalassemia Treatment Market Overview, By End User, 2015 - 2028 (USD Million)
11.1.5. Asia Pacific Thalassemia Treatment Market Overview, By Countries, 2015 - 2028 (USD Million)
11.1.5.1. India
11.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.5.1.2. India Thalassemia Treatment Market Overview, By Type, 2015 - 2028(USD Million)
11.1.5.1.3. India Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
11.1.5.1.4. Other Segment
11.1.5.2. China
11.1.5.2.1. Market Size and projections, 2015 - 2028(USD Million)
11.1.5.2.2. China Thalassemia Treatment Market Overview, By Type, 2015 - 2028(USD Million)
11.1.5.2.3. China Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
11.1.5.2.4. Other Segment
11.1.5.3. Japan
11.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.5.3.2. Japan Thalassemia Treatment Market Overview, By Type, 2015 - 2028(USD Million)
11.1.5.3.3. Japan Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028(USD Million)
11.1.5.3.4. Other Segment
11.1.5.4. South Korea
11.1.5.4.1. Market Size and projections, 2015 - 2028(USD Million)
11.1.5.4.2. South Korea Thalassemia Treatment Market Overview, By Type, 2015 - 2028(USD Million)
11.1.5.4.3. South Korea Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
11.1.5.4.4. Other Segment
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.5.5.2. Rest of Asia Pacific Thalassemia Treatment Market Overview, By Type, 2015 - 2028(USD Million)
11.1.5.5.3. Rest of Asia Pacific Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
11.1.5.5.4. Other Segment
Chapter 12. Middle East & Africa Thalassemia Treatment Market Overview, By Countries, 2015 - 2028 (USD Million)
12.1. Middle East & Africa Thalassemia Treatment Market Overview, 2015 - 2028 (USD Million)
12.1.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.2. Middle East & Africa Thalassemia Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
12.1.3. Middle East & Africa Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
12.1.4. Middle East & Africa Thalassemia Treatment Market Overview, By End User, 2015 - 2028 (USD Million)
12.1.5. Middle East & Africa Thalassemia Treatment Market Overview, By Countries, 2015 - 2028 (USD Million)
12.1.5.1. GCC
12.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.5.1.2. GCC Thalassemia Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
12.1.5.1.3. GCC Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
12.1.5.1.4. Other Segment
12.1.5.2. South Africa
12.1.5.2.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.5.2.2. South Africa Thalassemia Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
12.1.5.2.3. South Africa Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
12.1.5.2.4. Other Segment
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.5.3.2. Rest of Middle East & Africa Thalassemia Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
12.1.5.3.3. Rest of Middle East & Africa Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
12.1.5.3.4. Other Segment
Chapter 13. South America Thalassemia Treatment Market Overview, By Countries, 2015 - 2028 (USD Million)
13.1. South America Thalassemia Treatment Market Overview, 2015 - 2028 (USD Million)
13.1.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.2. South America Thalassemia Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
13.1.3. South America Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
13.1.4. South America Thalassemia Treatment Market Overview, By End User, 2015 - 2028 (USD Million)
13.1.5. South America Thalassemia Treatment Market Overview, By Countries, 2015- 2026 (USD Million)
13.1.6. Brazil
13.1.6.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.6.2. Brazil Thalassemia Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
13.1.6.3. Brazil Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
13.1.6.4. Other Segment
13.1.7. Argentina
13.1.7.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.7.2. Argentina Thalassemia Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
13.1.7.3. Argentina Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
13.1.7.4. Other Segment
13.1.8. Rest of South America
13.1.8.1. Market Size and projections, 2015 – 2028
13.1.8.2. Rest of South America Thalassemia Treatment Market Overview, By Type, 2015 - 2028 (USD Million)
13.1.8.3. Rest of South America Thalassemia Treatment Market Overview, By Diagnosis, 2015 - 2028 (USD Million)
13.1.8.4. Other Segment
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2021
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Size development
Chapter 15. Key Vendor Analysis
15.1. Bluebird bio Inc.
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Type Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Acceleron Pharma Inc.
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Type Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. Novartis AG
15.3.1. Company overview
15.3.2. Financial performance
15.3.3. Type Benchmarking
15.3.4. Recent initiatives
15.4. Celgene Corporation
15.5. Shire plc
15.6. Bellicum Pharmaceuticals
15.7. GlaxoSmithKline Plc
15.8. Others
Chapter 16. Thalassemia Treatment Market Cost Analysis
16.1. Thalassemia Treatment Market Key Offering Analysis
16.1.1. Key Offering
16.1.2. Price Trend of Key Type
16.1.3. Key Suppliers
16.1.4. Labor Cost
Chapter 17. Industrial Chain, Sourcing Strategy and Downstream Buyers
17.1. Thalassemia Treatment Market Industrial Chain Analysis
17.2. Upstream Offering Sourcing
17.3. Raw Material Sources of Thalassemia Treatment Market Major Manufacturers in 2021
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Type Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Type Progress in Related Size
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Thalassemia Treatment Market, 2015-2028 (USD Million)
4. Biochemical Sensor requirement, by country, 2015-2028 (USD Million)
5. North America Thalassemia Treatment Market, By Type, 2015-2028 (USD Million)
6. North America Thalassemia Treatment Market, By Diagnosis, 2015-2028 (USD Million)
7. North America Thalassemia Treatment Market, By End User, 2015-2028 (USD Million)
8. Europe Thalassemia Treatment Market, By Type, 2015-2028 (USD Million)
9. Europe Thalassemia Treatment Market, By Diagnosis, 2015-2028 (USD Million)
10. Europe Thalassemia Treatment Market, By End User, 2015-2028 (USD Million)
11. Asia Pacific Thalassemia Treatment Market, By Type, 2015-2028 (USD Million)
12. Asia Pacific Thalassemia Treatment Market, By Diagnosis, 2015-2028 (USD Million)
13. Asia Pacific Thalassemia Treatment Market, By End User, 2015-2028 (USD Million)
14. Middle East & Africa Thalassemia Treatment Market, By Type, 2015-2028 (USD Million)
15. Middle East & Africa Thalassemia Treatment Market, By Diagnosis, 2015-2028 (USD Million)
16. Middle East & Africa Thalassemia Treatment Market, By End User, 2015-2028 (USD Million)
17. South America Thalassemia Treatment Market, By Type, 2015-2028 (USD Million)
18. South America Thalassemia Treatment Market, By Diagnosis, 2015-2028 (USD Million)
19. South America Thalassemia Treatment Market, By End User, 2015-2028 (USD Million)
20. Global Thalassemia Treatment Market, Company Market Share, 2020 - 2028 (%)
21. Bluebird bio Inc.: Type Benchmarking
22. Bluebird bio Inc.: Financial Performance
23. Acceleron Pharma Inc.: Type Benchmarking
24. Acceleron Pharma Inc.: Financial Performance
25. Novartis AG: Type Benchmarking
26. Novartis AG: Financial Performance
27. Celgene Corporation: Type Benchmarking
28. Celgene Corporation: Financial Performance
29. Shire plc: Type Benchmarking
30. Shire plc: Financial Performance
31. Bellicum Pharmaceuticals: Type Benchmarking
32. Bellicum Pharmaceuticals: Financial Performance
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Thalassemia Treatment Market share, By Type, 2020 & 2028 (%)
10. Global Thalassemia Treatment Market share, by Blood Transfusion, By Type, 2015 - 2028 (USD Million)
11. Global Thalassemia Treatment Market share, by Chelating Therapy, By Type, 2015 - 2028 (USD Million)
12. Global Thalassemia Treatment Market share, by Bone Marrow Transplant, By Type, 2015 - 2028 (USD Million)
13. Global Thalassemia Treatment Market share, by Stem Cell Transplant, By Type, 2015 - 2028 (USD Million)
14. Global Thalassemia Treatment Market share, by Surgery, By Type, 2015 - 2028 (USD Million)
15. Global Thalassemia Treatment Market share, by Gene Therapy, By Type, 2015 - 2028 (USD Million)
16. Global Thalassemia Treatment Market share, by Other, By Type, 2015 - 2028 (USD Million)
17. Global Thalassemia Treatment Market share, By Diagnosis, 2020 & 2028 (%)
18. Global Thalassemia Treatment Market share, by Perinatal Testing, By Diagnosis, 2015 - 2028 (USD Million)
19. Global Thalassemia Treatment Market share, by Prenatal Testing, By Diagnosis, 2015 - 2028 (USD Million)
20. Global Thalassemia Treatment Market share, by Pre-Implantation, By Diagnosis, 2015 - 2028 (USD Million)
21. Global Thalassemia Treatment Market share, by Others, By Diagnosis, 2015 - 2028 (USD Million)
22. Global Thalassemia Treatment Market share, By End User, 2020 & 2028 (%)
23. Global Thalassemia Treatment Market share, by Hospitals, By End User, 2015 - 2028 (USD Million)
24. Global Thalassemia Treatment Market share, by Biotechnological Laboratories, By End User, 2015 - 2028 (USD Million)
25. Global Thalassemia Treatment Market share, by Diagnostic Laboratories, By End User, 2015 - 2028 (USD Million)
26. Global Thalassemia Treatment Market share, by Educational Research Institutes, By End User, 2015 - 2028 (USD Million)
27. Global Thalassemia Treatment Market share, by Pharmaceutical Industries, By End User, 2015 - 2028 (USD Million)
28. Global Thalassemia Treatment Market share, by Other, By End User, 2015 - 2028 (USD Million)
29. Global Thalassemia Treatment Market share, by Region, 2020 & 2028 (%)
30. Global Thalassemia Treatment Market share, by Region, 2015 - 2028(USD Million)
31. North America Thalassemia Treatment Market, 2015 - 2028(USD Million)
32. North America Thalassemia Treatment Market share, by Countries, 2020 & 2028 (%)
33. U.S. Thalassemia Treatment Market, 2015 - 2028(USD Million)
34. Canada Thalassemia Treatment Market, 2015 - 2028(USD Million)
35. Mexico Thalassemia Treatment Market, 2015 - 2028(USD Million)
36. Europe Thalassemia Treatment Market, 2015 - 2028(USD Million)
37. Europe Thalassemia Treatment Market share, by Countries, 2020 & 2028 (%)
38. Spain Thalassemia Treatment Market, 2015 - 2028(USD Million)
39. UK Thalassemia Treatment Market, 2015 - 2028(USD Million)
40. Italy Thalassemia Treatment Market, 2015 - 2028(USD Million)
41. Germany Thalassemia Treatment Market, 2015 - 2028(USD Million)
42. France Thalassemia Treatment Market, 2015 - 2028(USD Million)
43. Rest of Europe Thalassemia Treatment Market, 2015 - 2028(USD Million)
44. Asia-Pacific Thalassemia Treatment Market, 2015 - 2028(USD Million)
45. Asia-Pacific Thalassemia Treatment Market share, by Countries, 2020 & 2028 (%)
46. China Thalassemia Treatment Market, 2015 - 2028(USD Million)
47. India Thalassemia Treatment Market, 2015 - 2028(USD Million)
48. Australia Thalassemia Treatment Market, 2015 - 2028(USD Million)
49. Japan Thalassemia Treatment Market, 2015 - 2028(USD Million)
50. Rest of Asia-Pacific Thalassemia Treatment Market, 2015 - 2028(USD Million)
51. Middle East & Africa Thalassemia Treatment Market, 2015 - 2028(USD Million)
52. Middle East & Africa Thalassemia Treatment Market share, by Countries, 2020 & 2028 (%)
53. GCC Thalassemia Treatment Market, 2015 - 2028(USD Million)
54. South Africa Thalassemia Treatment Market, 2015 - 2028(USD Million)
55. Rest Of Middle East & Africa Thalassemia Treatment Market, 2015 - 2028(USD Million)
56. South America Thalassemia Treatment Market, 2015 - 2028(USD Million)
57. Brazil Thalassemia Treatment Market, 2015 - 2028(USD Million)
58. Mexico Thalassemia Treatment Market, 2015 - 2028(USD Million)
59. Argentina Thalassemia Treatment Market, 2015 - 2028(USD Million)
60. Rest Of South America Thalassemia Treatment Market, 2015 - 2028(USD Million)
The Leading Key Players in Global Thalassemia Treatment Market
